Literature DB >> 29852036

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.

Robert D Timmerman1, Chen Hu2,3, Jeff M Michalski4, Jeffrey C Bradley4, James Galvin5, David W Johnstone6, Hak Choy1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29852036      PMCID： PMC6117101          DOI： 10.1001/jamaoncol.2018.1258

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Feasibility of non-coplanar tomotherapy for lung cancer stereotactic body radiation therapy.

Authors:  Wensha Yang; Ryan Jones; Weiguo Lu; Constance Geesey; Stanley Benedict; Paul Read; James Larner; Ke Sheng
Journal:  Technol Cancer Res Treat       Date:  2011-08

Review 3.  Hypofractionation: lessons from complications.

Authors:  G H Fletcher
Journal:  Radiother Oncol       Date:  1991-01       Impact factor: 6.280

4.  Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis.

Authors:  Hubert Pan; Brent S Rose; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

Review 5.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Authors:  Andy Trotti; A Dimitrios Colevas; Ann Setser; Valerie Rusch; David Jaques; Volker Budach; Corey Langer; Barbara Murphy; Richard Cumberlin; C Norman Coleman; Philip Rubin
Journal:  Semin Radiat Oncol       Date:  2003-07       Impact factor: 5.934
  5 in total
  45 in total

1.  Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Authors:  Gregory M Videtic; Rebecca Paulus; Anurag K Singh; Joe Y Chang; William Parker; Kenneth R Olivier; Robert D Timmerman; Ritsuko R Komaki; James J Urbanic; Kevin L Stephans; Sue S Yom; Clifford G Robinson; Chandra P Belani; Puneeth Iyengar; Munther I Ajlouni; Darindra D Gopaul; Jorge B Gomez Suescun; Ronald C McGarry; Hak Choy; Jeffrey D Bradley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-12-01       Impact factor: 7.038

2.  Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer.

Authors:  Nikhil Sebastian; Trudy Wu; Erin Driscoll; Henning Willers; Suzanne Kelly; Hima Bindu Musunuru; Xiaokui Mo; Yubo Tan; Jose Bazan; Karl Haglund; Meng Xu-Welliver; Andrew M Baschnagel; Andrew Ju; Florence Keane; Terence M Williams
Journal:  Radiother Oncol       Date:  2019-06-05       Impact factor: 6.280

3.  Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.

Authors:  Alberto Cerra-Franco; Sheng Liu; Michella Azar; Kevin Shiue; Samantha Freije; Jason Hinton; Christopher R Deig; Donna Edwards; Neil C Estabrook; Susannah G Ellsworth; Ke Huang; Khalil Diab; Mark P Langer; Richard Zellars; Feng-Ming Kong; Jun Wan; Tim Lautenschlaeger
Journal:  Clin Lung Cancer       Date:  2018-12-29       Impact factor: 4.785

4.  Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT.

Authors:  William R Kennedy; Prashant Gabani; John Nikitas; Clifford G Robinson; Jeffrey D Bradley; Michael C Roach
Journal:  Radiother Oncol       Date:  2019-08-31       Impact factor: 6.280

5.  Response evaluation after stereotactic ablative radiotherapy for localised non-small-cell lung cancer: an equipoise of available resource and accuracy.

Authors:  Andre G Gouveia; Osbert C Zalay; Kevin Lm Chua; Fabio Ynoe Moraes
Journal:  Br J Radiol       Date:  2019-12-11       Impact factor: 3.039

6.  Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLC.

Authors:  William R Kennedy; Pamela P Samson; Prashant Gabani; John Nikitas; Jeffrey D Bradley; Michael C Roach; Clifford G Robinson
Journal:  Radiother Oncol       Date:  2020-07-03       Impact factor: 6.280

Review 7.  Radiotherapy and Immunotherapy Combinations for Lung Cancer.

Authors:  Vishesh Agrawal; Kimberly Thomas Benjamin; Eric C Ko
Journal:  Curr Oncol Rep       Date:  2020-11-19       Impact factor: 5.075

8.  Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.

Authors:  Melissa A Frick; Gary D Kao; Louise Aguarin; Chimbu Chinniah; Samuel Swisher-McClure; Abigail T Berman; William P Levin; Keith A Cengel; Cristina DeCesaris; Stephen M Hahn; Jay F Dorsey; Charles B Simone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-07-02       Impact factor: 7.038

Review 9.  Management of local recurrences and regional failure in early stage non-small cell lung cancer after stereotactic body radiation therapy.

Authors:  Sameera S Kumar; Ronald C McGarry
Journal:  Transl Lung Cancer Res       Date:  2019-09

Review 10.  Pathologic response after modern radiotherapy for non-small cell lung cancer.

Authors:  Simon F Roy; Alexander V Louie; Moishe Liberman; Philip Wong; Houda Bahig
Journal:  Transl Lung Cancer Res       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.